COVID-19: AIIMS panel gives nod for human trial of indigenous vaccine
The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.
Jul 19, 2020, 20:00 PM IST
